112 related articles for article (PubMed ID: 33169474)
1. The association of the neutrophil-lymphocyte ratio with the presence of minimal residual disease and outcome in patients with Stage II colon cancer treated with surgery alone.
Murray NP; Villalon R; Orrego S; Guzman E
Colorectal Dis; 2021 Apr; 23(4):805-813. PubMed ID: 33169474
[TBL] [Abstract][Full Text] [Related]
2. Immune Dysfunction as Measured by the Systemic Immune-Inflammation Index is Associated with the Sub-Type of Minimal Residual Disease and Outcome in Stage II Colon Cancer Treated with Surgery alone.
Murray NP; Villalon R; Orrego S; Guzman E
Asian Pac J Cancer Prev; 2021 Aug; 22(8):2391-2397. PubMed ID: 34452551
[TBL] [Abstract][Full Text] [Related]
3. Improvement in the Neutrophil-Lymphocyte Ratio after Combined Fluorouracil, Leucovorina and Oxaliplatino based (FOLFOX) Chemotherapy for Stage III Colon Cancer is Associated with Improved Minimal Residual Disease and Outcome.
Murray NP; Villalon R; Hartmann D; Rodriguez PM; Aedo S
Asian Pac J Cancer Prev; 2022 Feb; 23(2):591-599. PubMed ID: 35225472
[TBL] [Abstract][Full Text] [Related]
4. Improvement in immune dysfunction after FOLFOX chemotherapy for Stage III colon cancer is associated with improved minimal residual disease prognostic subtype and outcome.
Murray NP; Villalon R; Hartmann D; Rodriguez MP; Aedo S
Colorectal Dis; 2021 Nov; 23(11):2879-2893. PubMed ID: 34473913
[TBL] [Abstract][Full Text] [Related]
5. Effect of FOLFOX on minimal residual disease in Stage III colon cancer and risk of relapse.
Murray NP; Aedo S; Villalon R; López MA; Minzer S; Muñoz L; Orrego S; Contreras L; Arzeno L; Guzman E
Ecancermedicalscience; 2019; 13():935. PubMed ID: 31281432
[TBL] [Abstract][Full Text] [Related]
6. The Possible Role of Matrix Metalloprotienase-2 in the Relapse in Patients with Stage II Colon Cancer Treated by Curative Surgery.
Murray NP; Villalon R; Aedo S; Hartmann D; Rodriguez MP
Asian Pac J Cancer Prev; 2023 Oct; 24(10):3373-3379. PubMed ID: 37898840
[TBL] [Abstract][Full Text] [Related]
7. Subtypes of minimal residual disease and outcome for stage II colon cancer treated by surgery alone.
Murray NP; Aedo S; Villalon R; Albarran V; Orrego S; Guzman E
Ecancermedicalscience; 2020; 14():1119. PubMed ID: 33209110
[TBL] [Abstract][Full Text] [Related]
8. [Circulating prostate cells and bone marrow micro-metastasis and not treatment modality determine the risk and time to biochemical failure in low risk prostate cancer.].
Murray NP; Aedo S; Fuentealba C; Salazar A; Reyes E; Lopez MA; Minzer S
Arch Esp Urol; 2019 Dec; 72(10):1000-1009. PubMed ID: 31823848
[TBL] [Abstract][Full Text] [Related]
9. [Circulating prostate cells and bone marrow micrometastasis are determinant in risk and time to biochemical progression in localized prostate cancer.].
Murray NP; Aedo S; Fuentealba C; Reyes E; Minzer S; Salazar A
Arch Esp Urol; 2019 Jun; 72(5):471-482. PubMed ID: 31223125
[TBL] [Abstract][Full Text] [Related]
10. Neutrophil-to-lymphocyte ratio is a prognostic factor for colon cancer: a propensity score analysis.
Mazaki J; Katsumata K; Kasahara K; Tago T; Wada T; Kuwabara H; Enomoto M; Ishizaki T; Nagakawa Y; Tsuchida A
BMC Cancer; 2020 Sep; 20(1):922. PubMed ID: 32977767
[TBL] [Abstract][Full Text] [Related]
11. [Impact of neutrophil-to-lymphocyte ratio on the prognosis of patients with locally advanced colorectal cancer].
Jiang H; Wang H; Li A; Tang E; Chen Y; Wang A; Deng X; Lin M
Zhonghua Wei Chang Wai Ke Za Zhi; 2017 May; 20(5):550-554. PubMed ID: 28534334
[TBL] [Abstract][Full Text] [Related]
12. Effect of preoperative neutrophil-lymphocyte ratio on the surgical outcomes of stage II colon cancer patients who do not receive adjuvant chemotherapy.
Hung HY; Chen JS; Yeh CY; Changchien CR; Tang R; Hsieh PS; Tasi WS; You JF; You YT; Fan CW; Wang JY; Chiang JM
Int J Colorectal Dis; 2011 Aug; 26(8):1059-65. PubMed ID: 21479566
[TBL] [Abstract][Full Text] [Related]
13. Neutrophil-Lymphocyte Ratio and Circulating Tumor Cells Counts Predict Prognosis in Gastrointestinal Cancer Patients.
Qian C; Cai R; Zhang W; Wang J; Hu X; Zhang Y; Jiang B; Yuan H; Liu F
Front Oncol; 2021; 11():710704. PubMed ID: 34307180
[TBL] [Abstract][Full Text] [Related]
14. Neutrophils to lymphocytes ratio as a useful prognosticator for stage II colorectal cancer patients.
Dimitriou N; Felekouras E; Karavokyros I; Alexandrou A; Pikoulis E; Griniatsos J
BMC Cancer; 2018 Dec; 18(1):1202. PubMed ID: 30509242
[TBL] [Abstract][Full Text] [Related]
15. [An elevated neutrophil/lymphocyte ratio is associated with poor prognosis in stage II resected colon cancer].
Urrejola GI; Bambs CE; Espinoza MA; Gellona J; Zúñiga AM; Molina ME; Bellolio F; Miguieles R; Campbell JM; Pinedo GA
Rev Med Chil; 2013 May; 141(5):602-8. PubMed ID: 24089275
[TBL] [Abstract][Full Text] [Related]
16. Peripheral Neutrophil to Lymphocyte Ratio Improves Prognostication in Colon Cancer.
Rashtak S; Ruan X; Druliner BR; Liu H; Therneau T; Mouchli M; Boardman LA
Clin Colorectal Cancer; 2017 Jun; 16(2):115-123.e3. PubMed ID: 28365393
[TBL] [Abstract][Full Text] [Related]
17. Neutrophil to lymphocyte ratio as a predictor of response to neoadjuvant chemotherapy and survival in oesophageal adenocarcinoma.
Powell AGMT; Chin C; Coxon AH; Chalishazar A; Christian A; Roberts SA; Lewis WG
BJS Open; 2020 Jun; 4(3):416-423. PubMed ID: 32232963
[TBL] [Abstract][Full Text] [Related]
18. Assessment of the prognostic role of neutrophil-to-lymphocyte ratio following complete resection of thymoma.
Muriana P; Carretta A; Ciriaco P; Bandiera A; Negri G
J Cardiothorac Surg; 2018 Nov; 13(1):119. PubMed ID: 30454002
[TBL] [Abstract][Full Text] [Related]
19. Preoperative neutrophil-to-lymphocyte ratio predicts clinical outcome in patients with stage II and III colon cancer.
Absenger G; Szkandera J; Stotz M; Postlmayr U; Pichler M; Ress AL; Schaberl-Moser R; Loibner H; Samonigg H; Gerger A
Anticancer Res; 2013 Oct; 33(10):4591-4. PubMed ID: 24123035
[TBL] [Abstract][Full Text] [Related]
20. Leukocyte and platelet counts as prognostic values of testicular germ cell tumours.
Herraiz-Raya L; Moreillo-Vicente L; Martínez-Ruiz J; Agustí-Martínez A; Fernández-Anguita PJ; Esper-Rueda JA; Salce-Marte L; Armas-Álvarez A; Díaz de Mera-Sánchez Migallón I; Martínez-Alfaro C; Giménez-Bachs JM; Donate-Moreno MJ; Salinas-Sánchez AS
Actas Urol Esp (Engl Ed); 2019; 43(6):284-292. PubMed ID: 31085041
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]